Takeda Yakuhin Kogyo KK header image

Takeda Yakuhin Kogyo KK

TAK

Equity

ISIN null / Valor 11292411

New York Stock Exchange, Inc (2026-02-27)
USD 18.75+1.19%

Takeda Yakuhin Kogyo KK
UMushroom community rating:

star star star star star
5.00 2 votes No rating yet
NegativeNeutralPositive

About company

Takeda Yakuhin Kogyo K.K. is a Japanese pharmaceutical manufacturer that develops, produces and markets medicines and related chemical intermediates for healthcare markets, supplying hospitals, pharmacies and distributors at home and abroad. Its business combines research and formulation work with commercial manufacturing—covering active pharmaceutical ingredient production, finished‑dose formulation, quality control and regulatory compliance—and it also provides contract manufacturing and outsourcing services to other drugmakers. The company’s product mix spans prescription (ethical) medicines, consumer health/OTC products and bulk pharmaceutical ingredients, with operations organized to support manufacturing scale, supply‑chain reliability and customer distribution channels.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

30.8%1Y
21.8%3Y
12.2%5Y

Performance

20.5%1Y
18.8%3Y
19.7%5Y

Volatility

Market cap

59235 M

Market cap (USD)

Daily traded volume (Shares)

2,145,100

Daily traded volume (Shares)

1 day high/low

13.25 / 13.155

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

5.00

2 votes
Performance:
starstarstarstarstar
4.25
Innovation:
starstarstarstarstar
3.25
Society:
starstarstarstarstar
3.50
Nature:
starstarstarstarstar
3.50
Adam Hakimi Bin Hasni
United Kingdom, 04 Nov 2025
star star star star star
A good company for long term investment as pharmaceutical and healthcare is a much needed service in Japan
sofia nava
Switzerland, 29 Oct 2025
star star star star star
.

EQUITIES OF THE SAME SECTOR

Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC Valor: 2324471
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.30%GBP 13.14
Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc Amphastar Pharmaceuticals Inc Valor: 24511852
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-23.63%USD 20.23
Medtronic PLC
Medtronic PLC Medtronic PLC Valor: 25187155
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.65%USD 97.66
4basebio PLC
4basebio PLC 4basebio PLC Valor: 112829117
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.57%EUR 6.26
Cassava Sciences Inc
Cassava Sciences Inc Cassava Sciences Inc Valor: 46983284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.98%USD 2.28
Edwards Lifesciences Corp
Edwards Lifesciences Corp Edwards Lifesciences Corp Valor: 1065343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.66%USD 86.47
Centene Corp
Centene Corp Centene Corp Valor: 1313733
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.54%USD 44.88
Getinge AB
Getinge AB Getinge AB Valor: 84926
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.10%SEK 202.90
Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc Ultragenyx Pharmaceutical Inc Valor: 22860122
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.52%USD 23.39
Resmed Inc
Resmed Inc Resmed Inc Valor: 321632
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.31%USD 256.26